Evaluation of continuous infusion low‐dose 5‐azacytidine in the treatment of myelodysplastic syndromes

The treatment of myelodysplastic syndromes (MDS) is both difficult and controversial. In the current study, we evaluated the efficacy of low‐dose 5‐azacytidine in the treatment of this disorder. Fifteen patients with MDS were entered on study to be treated with 5‐azacytidine by continuous intravenou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 1991-06, Vol.37 (2), p.100-104
Hauptverfasser:	Chitambar, Christopher R., Libnoch, Joseph A., Matthaeus, William G., Ash, Robert C., Ritch, Paul S., Anderson, Tom
Format:	Artikel
Sprache:	eng
Schlagworte:	5‐azacytidine Adult Aged Antineoplastic agents Azacitidine - adverse effects Azacitidine - therapeutic use Biological and medical sciences Blood Transfusion Bone Marrow - drug effects Erythrocyte Transfusion Female Humans Infusions, Intravenous Leukocyte Count - drug effects Male Medical sciences Middle Aged myelodysplastic syndromes Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - therapy Neutrophils - pathology Pharmacology. Drug treatments Platelet Count - drug effects treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!